NUVA — NuVasive Share News
0.000.00%
Last trade - 00:00HealthcareBalancedMid Cap
- $2.08bn
- $2.80bn
- $1.20bn
Brief: Nuvasive Says Repaid And Settled In Full Its 2.25% Convertible Senior Notes Due 2021 At Their Scheduled Maturity
Brief: NuVasive Says Co, International Spine Study Group Foundation Announced Continuation Of Long-Term Partnership
NuVasive: Needham expects some recovery in H2 on multiple growth drivers
Brief: NuVasive Reports Q4 Sales Fell 6% To $291.8 Mln
Brief: NuVasive Acquires Simplify Medical
Brief: Dr. Siddhartha Kadia To Join Nuvasive Board Of Directors
Brief: Nuvasive Inc - On Jan 29, 2021, Siddhartha C. Kadia Was Elected To Board Which Increased Size Of Board From Nine To Ten Members
Brief: Nuvasive's Thoracolumbar Interbody Portfolio Receives First Clearance In U.S For Treatment Of Sagittal Deformities
NuVasive: Down as brokerages cut PT on slower-than-expected recovery
Brief: Nuvasive Announces Third Quarter 2020 Financial Results
Brief: Nuvasive Announces New Organizational Structure To Align Global Commercial Operations And Product & Services Organization With Long-Term Strategy
Needham says overturning of ACA may spell trouble for some MedTech cos
Covid: 19 vaccine approval won't immediately hit med tech sector - Needham
Brief: Nuvasive Announces Second Quarter 2020 Financial Results
Brief: Nuvasive Announces Certain Preliminary Unaudited Second Quarter 2020 Results
JPM expects most MedTech cos to beat relatively stale Q2 Street sales forecasts
NuVasive: Needham turns bullish on rapid recovery in surgery volumes
Brief: Nuvasive Says Anticipate Q2 Net Sales To Be Greater Than 55% Of Q2 2019 Net Sales
Brief: NuVasive Announces Full Exercise Of Option By Initial Purchasers To Purchase Additional 1.00% Convertible Senior Notes Due 2023